David L. Clark

NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ.

Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation.

Regence BlueCross BlueShield of Oregon provides health insurance services. The firm provides life, disability and short term medical insurance services to members in Idaho, Utah and Washington. The company was founded in 1941 and is headquartered in Portland, OR.

AgriDyne Technologies, Inc. specializes in pesticides. The company is based in Salt Lake City, UT. AgriDyne Technologies was acquired by biosys, Inc. on March 18, 1996 for $8.15 million.

NPS Allelix Corp. develops protein therapeutics and neuropharmaceuticals. It provides research and development services in the physical, engineering, and life sciences. The company was founded in 1988 and is headquartered in Mississauga, Canada.